135 related articles for article (PubMed ID: 7959906)
41. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
Welsh N; Sandler S
Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791
[TBL] [Abstract][Full Text] [Related]
42. Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells.
Hao W; Palmer JP
J Interferon Cytokine Res; 1995 Dec; 15(12):1075-81. PubMed ID: 8746789
[TBL] [Abstract][Full Text] [Related]
43. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
Gysemans CA; Cardozo AK; Callewaert H; Giulietti A; Hulshagen L; Bouillon R; Eizirik DL; Mathieu C
Endocrinology; 2005 Apr; 146(4):1956-64. PubMed ID: 15637289
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism.
Eizirik DL; Welsh M; Strandell E; Welsh N; Sandler S
Endocrinology; 1990 Nov; 127(5):2290-7. PubMed ID: 2171911
[TBL] [Abstract][Full Text] [Related]
45. Function of rat pancreatic islets exposed to interleukin-18 in vitro.
Krook H; Wallström J; Sandler S
Autoimmunity; 1999; 29(4):263-7. PubMed ID: 10433081
[TBL] [Abstract][Full Text] [Related]
46. Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets.
Riachy R; Vandewalle B; Belaich S; Kerr-Conte J; Gmyr V; Zerimech F; d'Herbomez M; Lefebvre J; Pattou F
J Endocrinol; 2001 Apr; 169(1):161-8. PubMed ID: 11250657
[TBL] [Abstract][Full Text] [Related]
47. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
48. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
49. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
50. Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events.
Eizirik DL; Sandler S
Diabetologia; 1989 Nov; 32(11):769-73. PubMed ID: 2687062
[TBL] [Abstract][Full Text] [Related]
51. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
[TBL] [Abstract][Full Text] [Related]
52. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas.
Bourlon PM; Billaudel B; Faure-Dussert A
J Endocrinol; 1999 Jan; 160(1):87-95. PubMed ID: 9854180
[TBL] [Abstract][Full Text] [Related]
53. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
54. Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta.
Laychock SG
Biochem Pharmacol; 1998 May; 55(9):1453-64. PubMed ID: 10076538
[TBL] [Abstract][Full Text] [Related]
55. Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta.
Bolaffi JL; Rodd GG; Wang J; Grodsky GM
Endocrinology; 1994 Feb; 134(2):537-42. PubMed ID: 7507826
[TBL] [Abstract][Full Text] [Related]
56. Time course study of insulin secretion after 1,25-dihydroxyvitamin D3 administration.
Kadowaki S; Norman AW
Endocrinology; 1985 Nov; 117(5):1765-71. PubMed ID: 3899614
[TBL] [Abstract][Full Text] [Related]
57. Direct in vitro effect of 1,25-dihydroxyvitamin D3 on islets insulin secretion in vitamin deficient rats: influence of vitamin D3 pretreatment.
Billaudel B; Faure A; Labriji-Mestaghanmi H; Sutter BC
Diabete Metab; 1989; 15(2):85-7. PubMed ID: 2544468
[TBL] [Abstract][Full Text] [Related]
58. Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets.
Wolden-Kirk H; Overbergh L; Gysemans C; Brusgaard K; Naamane N; Van Lommel L; Schuit F; Eizirik DL; Christesen H; Mathieu C
J Steroid Biochem Mol Biol; 2013 Jul; 136():68-79. PubMed ID: 23137852
[TBL] [Abstract][Full Text] [Related]
59. Not all insulin secretagogues sensitize pancreatic islets to recombinant human interleukin 1 beta.
Johannesen J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1990 Oct; 123(4):445-52. PubMed ID: 1700570
[TBL] [Abstract][Full Text] [Related]
60. Stimulatory effect of 1,25-dihydroxyvitamin D3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats.
Billaudel BJ; Delbancut AP; Sutter BC; Faure AG
Steroids; 1993 Jul; 58(7):335-41. PubMed ID: 8212082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
